BM
bioMérieux S.A.
BMXXY · OTC
$8.50 -2.30% (-$0.20)
1M -4.06%
Market Cap 8.62B €
P/E Ratio 22.58x
Div. Yield 1.34%
ROE 9.24%
Bulios Fair Price
$7.12
16.2% downside
Trenutna cena
$8.5
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BMXXY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
9/9Valuation
71 /100
Cheap P/E 22.58x
P/FCF 19.81x
EV/EBITDA 8.87x
Growth
43 /100
Stable EPS growth 5.57%
Book val. growth 4.39%
Rev. growth 2.89%
Profitability
71 /100
Strong Gross margin 52.63%
FCF margin 11.13%
Net margin 9.77%
Quality
50 /100
Average ROIC 8.77%
Asset turnover 0.70x
ROE 9.24%
Debt
100 /100
Low Debt/Equity 0.11x
Net debt/EBITDA -0.11x
Current ratio 2.39x
Stability
93 /100
Stable Beta 0.57x
Profitable years 6
Rev. volatility 5.07%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BMXXY
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Pierre Boulud
Employees
15,078
Headquarters
Marcy l'Étoile